Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Neurology

The Biology & Diagnosis of AVED

At a Glance

Ataxia with vitamin E deficiency (AVED) is caused by disease-causing changes in both copies of the TTPA gene. Diagnosis uses very low vitamin E, lipid-adjusted testing, TTPA genetic testing, and tests that rule out Friedreich ataxia and malabsorption.

To understand Ataxia with Vitamin E Deficiency (AVED), it helps to think of your liver as a central distribution warehouse for the body. While your gut is perfectly capable of absorbing vitamin E from your food, a specific “gatekeeper” protein in the liver is required to package it into lipoproteins for circulation in the bloodstream [1][2].

The Role of the TTPA Gene

The TTPA gene provides the instructions for making a protein called alpha-tocopherol transfer protein (α-TTP) [2]. This protein has one primary job: it selectively grabs alpha-tocopherol (the most active form of vitamin E) and loads it into transport vehicles called lipoproteins that carry it to your brain, nerves, and muscles [1][3].

In a person with AVED, mutations in the TTPA gene mean that the α-TTP protein is either missing or broken [4]. Without this gatekeeper, the liver cannot adequately package vitamin E into lipoproteins. Although vitamin E can be stored, the failure in circulating delivery means your nervous system is left without the antioxidant protection it needs to stay healthy [2][3].

Why “Lipid-Adjusted” Testing is Crucial

Vitamin E is fat-soluble, meaning it does not travel through the blood alone; it must “hitch a ride” on fats and cholesterol [5]. Because of this, a simple vitamin E blood test can sometimes be misleading.

  • The Problem with Raw Numbers: If a person has very high cholesterol, their raw vitamin E level might appear to be in the normal range simply because there are so many “vehicles” in the blood. However, they may still be functionally deficient [6].
  • The Solution: Doctors often use a lipid-adjusted calculation to get a true picture of your vitamin E status [7]. They compare the amount of alpha-tocopherol to the total amount of lipids (cholesterol and triglycerides) in your blood [6]. Do not try to calculate this ratio on your own; rely on your doctor and your specific laboratory’s reference ranges.

Confirming the Diagnosis

Because AVED looks so similar to other conditions, doctors follow a specific diagnostic path to be certain.

  1. Biochemical Testing: A blood test typically shows markedly low levels of alpha-tocopherol [8]. While a typical deficiency threshold is below 12 µmol/L, values depend on the lab assay, and some patients have levels that are near zero (sometimes reported as less than 1.7 mg/L or 1.7 µg/mL) [9][8].
  2. Genetic Testing: The “gold standard” for diagnosis is identifying pathogenic or likely pathogenic biallelic variants in the TTPA gene [4]. “Biallelic” means you have two disease-causing mutations—one inherited from each parent. Geneticists may use Sanger sequencing or exome sequencing to find these specific errors [10][11]. Finding a “Variant of Uncertain Significance” (VUS) does not confirm AVED.
  3. Ruling Out Friedreich Ataxia (FRDA): Because AVED and FRDA share almost identical symptoms, doctors often run a genetic test for the FXN gene [11]. This test must specifically look for an “intronic GAA repeat expansion,” which standard exome sequencing often misses [12]. A negative FXN test alone does not prove AVED.
  4. Ruling Out Malabsorption: Clinicians will also ensure the deficiency is not caused by secondary issues, like Abetalipoproteinemia or Cystic Fibrosis, which prevent the gut from soaking up fats and vitamins [13][14][15].

Understanding Autosomal Recessive Inheritance

AVED is an autosomal recessive condition. When both parents are carriers of a pathogenic TTPA variant, each pregnancy has a 25% chance of being affected by AVED, a 50% chance of being a carrier, and a 25% chance of being unaffected. Family members and partners may benefit from speaking with a genetic counselor to discuss carrier testing and family planning.

Reading Your Lab Reports

When you look at your or your child’s lab results, pay close attention to three specific areas:

  • Alpha-tocopherol (Vitamin E): Look for levels that are significantly below the reference range provided by the lab [8].
  • Lipid Panel: Check your Total Cholesterol and Triglycerides. If these are high or low, ask your doctor for the lipid-adjusted ratio [6].
  • Genetic Findings: Look for the term “Pathogenic” or “Likely Pathogenic” next to the TTPA gene. Confirm that two variants were found [10].

Understanding these technical markers can help you have more productive conversations with your neurology and genetics team.

Common questions in this guide

What causes ataxia with vitamin E deficiency?
AVED is caused by disease-causing variants in both copies of the TTPA gene. These variants disrupt alpha-tocopherol transfer protein, so the liver cannot package enough vitamin E for delivery through the blood to the nervous system.
How is AVED confirmed?
Doctors usually look for a very low alpha-tocopherol, or vitamin E, level, interpreted with the laboratory’s reference range and often adjusted for blood lipids. Confirmation relies on finding pathogenic or likely pathogenic variants in both copies of TTPA. A variant of uncertain significance by itself does not confirm AVED.
Why does vitamin E testing need lipid adjustment?
Vitamin E travels through the blood attached to fats and cholesterol, so a raw level can look normal when cholesterol is high. A lipid-adjusted result compares alpha-tocopherol with blood lipids such as cholesterol and triglycerides. Your doctor should interpret the result using your laboratory’s method and reference range.
What tests help distinguish AVED from Friedreich ataxia?
Because AVED and Friedreich ataxia can cause similar symptoms, doctors may test the TTPA and FXN genes. The FXN test needs to look for a specific intronic GAA repeat expansion, a repeated DNA sequence that standard exome sequencing can miss. A negative FXN test alone does not prove AVED.
How is AVED inherited?
AVED is autosomal recessive, meaning a person usually has a disease-causing TTPA variant in both gene copies, one inherited from each parent. When both parents are carriers, each pregnancy has a 25% chance of AVED, a 50% chance of being a carrier, and a 25% chance of being unaffected.
Can another condition cause a low vitamin E level?
Yes. Abetalipoproteinemia and cystic fibrosis can cause low vitamin E by impairing absorption of fats and fat-soluble vitamins in the gut. Clinicians may consider these and other secondary causes when interpreting vitamin E results.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my child's (or my) specific alpha-tocopherol level on the most recent blood test, and how does it compare to the normal range?
  2. 2.Can you help me calculate the lipid-adjusted vitamin E level using my total cholesterol and triglyceride results?
  3. 3.Does the genetic report confirm 'biallelic' mutations, meaning one from each parent, or do we need further testing for family members?
  4. 4.Since the symptoms of AVED and Friedreich Ataxia are so similar, has a genetic test for the FXN gene definitely ruled out Friedreich Ataxia?
  5. 5.Are there any signs of malabsorption, like very low cholesterol or GI symptoms, that might suggest a different cause for the low vitamin E?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Screening of α-Tocopherol Transfer Protein Sensitive Genes in Human Hepatoma Cells (HepG2).

    Qu YH, Fu JC, Liu K, et al.

    International journal of molecular sciences 2016; (17(7)).

    PMID: 27355945
  2. 2

    α-Tocopherol transfer protein (α-TTP).

    Arai H, Kono N

    Free radical biology & medicine 2021; (176()):162-175 doi:10.1016/j.freeradbiomed.2021.09.021.

    PMID: 34563650
  3. 3

    Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein.

    Chung S, Ghelfi M, Atkinson J, et al.

    The Journal of biological chemistry 2016; (291(33)):17028-39 doi:10.1074/jbc.M116.734210.

    PMID: 27307040
  4. 4

    Ataxia with vitamin e deficiency in norway.

    Elkamil A, Johansen KK, Aasly J

    Journal of movement disorders 2015; (8(1)):33-6 doi:10.14802/jmd.14030.

    PMID: 25614784
  5. 5

    Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease.

    Galli F, Bonomini M, Bartolini D, et al.

    Antioxidants (Basel, Switzerland) 2022; (11(5)) doi:10.3390/antiox11050989.

    PMID: 35624853
  6. 6

    The low prevalence rate of vitamin E deficiency in urban adults of Wuhan from central China: findings from a single-center, cross-sectional study.

    Shen Y, Liu K, Luo X, Cheng L

    European journal of medical research 2023; (28(1)):141 doi:10.1186/s40001-023-01103-9.

    PMID: 36998030
  7. 7

    Oral Tocofersolan Corrects or Prevents Vitamin E Deficiency in Children With Chronic Cholestasis.

    Thébaut A, Nemeth A, Le Mouhaër J, et al.

    Journal of pediatric gastroenterology and nutrition 2016; (63(6)):610-615 doi:10.1097/MPG.0000000000001331.

    PMID: 27429423
  8. 8

    Ataxia With Vitamin E Deficiency Syndrome and a Novel TTPA Variant: A Paired Case Report.

    Baso G, Magri F, Sciacco M, et al.

    Neurology. Genetics 2026; (12(3)):e200399 doi:10.1212/NXG.0000000000200399.

    PMID: 42164107
  9. 9

    Suboptimal Serum α-Tocopherol Concentrations Observed among Younger Adults and Those Depending Exclusively upon Food Sources, NHANES 2003-20061-3.

    McBurney MI, Yu EA, Ciappio ED, et al.

    PloS one 2015; (10(8)):e0135510 doi:10.1371/journal.pone.0135510.

    PMID: 26287975
  10. 10

    Analysis of clinical pedigree characteristics in Chinese patients with ataxia with vitamin E deficiency.

    Lv P, Liu L, Hao Y, et al.

    Molecular genetics and metabolism 2026; (148(4)):110167 doi:10.1016/j.ymgme.2026.110167.

    PMID: 42259017
  11. 11

    A first description of ataxia with vitamin E deficiency associated with MT-TG gene mutation.

    Maalej M, Kammoun F, Kharrat M, et al.

    Acta neurologica Belgica 2021; (121(6)):1733-1740 doi:10.1007/s13760-020-01490-4.

    PMID: 32979145
  12. 12

    Friedreich's Ataxia: Clinical Presentation of a Compound Heterozygote Child with a Rare Nonsense Mutation and Comparison with Previously Published Cases.

    Rao VK, DiDonato CJ, Larsen PD

    Case reports in neurological medicine 2018; (2018()):8587203 doi:10.1155/2018/8587203.

    PMID: 30159187
  13. 13

    Efficacy of two vitamin E formulations in patients with abetalipoproteinemia and chylomicron retention disease.

    Cuerq C, Henin E, Restier L, et al.

    Journal of lipid research 2018; (59(9)):1640-1648 doi:10.1194/jlr.M085043.

    PMID: 30021760
  14. 14

    Lipids Responsible for Intestinal or Hepatic Disorder: When to Suspect a Familial Intestinal Hypocholesterolemia?

    Sissaoui S, Cochet M, Poinsot P, et al.

    Journal of pediatric gastroenterology and nutrition 2021; (73(1)):4-8 doi:10.1097/MPG.0000000000003145.

    PMID: 33853111
  15. 15

    Validation of Knock-Out Caco-2 TC7 Cells as Models of Enterocytes of Patients with Familial Genetic Hypobetalipoproteinemias.

    Bordat C, Vairo D, Cuerq C, et al.

    Nutrients 2023; (15(3)) doi:10.3390/nu15030505.

    PMID: 36771214

This page explains the biology and diagnostic testing of AVED for informational purposes only and does not constitute medical advice. Your neurologist and genetics team should interpret your specific vitamin E, lipid, and genetic results.

Get notified when new evidence is published on Ataxia with vitamin E deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.